Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2019

Jan 31, 2020

SELL
$12.97 - $15.94 $505,155 - $620,831
-38,948 Closed
0 $0
Q3 2019

Nov 13, 2019

BUY
$14.75 - $20.87 $422,779 - $598,196
28,663 Added 278.69%
38,948 $591,000
Q2 2019

Jul 29, 2019

SELL
$14.71 - $19.79 $7,913 - $10,647
-538 Reduced 4.97%
10,285 $203,000
Q1 2019

Apr 22, 2019

BUY
$13.73 - $16.87 $148,599 - $182,584
10,823 New
10,823 $180,000

Others Institutions Holding KURA

About Kura Oncology, Inc.


  • Ticker KURA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 66,893,000
  • Market Cap $603M
  • Description
  • Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A p...
More about KURA
Track This Portfolio

Track Hamilton Lane Advisors LLC Portfolio

Follow Hamilton Lane Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hamilton Lane Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hamilton Lane Advisors LLC with notifications on news.